Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma

09 December 2020: Database Analysis

Qinke Li ^ABCE , Wenbo Yang ^CD , Maoqing Lu ^DF , Ronggui Zhang ^AG*

DOI: 10.12659/MSM.927078

Med Sci Monit 2020; 26:e927078

Supplementary Table 3 Differentially expressed genes associated with prognosis of clear cell renal cell carcinoma.

Gene	HR	HR.95L	HR.95H
HMGA1	1.2562	1.003	1.5732
ARHGAP6	0.7363	0.5474	0.9905
PDZK1	0.8875	0.7923	0.994
ABCB1	0.8803	0.7809	0.9923
TCN1	1.1007	1.0062	1.2042
SLC2A3	1.2726	1.025	1.58
LIN7A	0.8515	0.7423	0.9769
FOXJ1	1.1326	1.0196	1.2581
ANO3	0.8665	0.7684	0.977
EPHA4	0.7864	0.646	0.9574
ADAMTS15	1.2563	1.0449	1.5105
UGT3A1	0.9266	0.8721	0.9844
SLC22A2	0.9172	0.8564	0.9823
DHRS3	0.6653	0.4867	0.9094
SPTLC3	0.7594	0.6179	0.9334
SLC17A3	0.9191	0.864	0.9778
CALCRL	0.7698	0.6354	0.9325
VAV3	0.7431	0.5982	0.9231
SCG5	1.1757	1.0457	1.3219
IRGM	1.3694	1.0944	1.7134
TINAG	0.8977	0.8313	0.9693
TF	1.1275	1.0357	1.2275
SLC44A4	0.827	0.723	0.9459
C1R	1.2622	1.0767	1.4796
LINC00313	1.3548	1.106	1.6595
PKHD1	0.8696	0.7954	0.9507
C1orf194	1.3722	1.1309	1.6651
MMP24	0.7379	0.6154	0.8849
TMEM158	1.3198	1.1219	1.5525
ACE2	0.8881	0.8299	0.9505
NTN4	0.7366	0.6338	0.8559
HSPA4L	0.6056	0.4757	0.7711